id | C00003663 |
---|---|
Name | Oestrone |
CAS RN | 53-16-7 |
Standard InChI | InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-16,19H,2,4,6-9H2,1H3/t14-,15-,16+,18+/m1/s1 |
Standard InChI (Main Layer) | InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-16,19H,2,4,6-9H2,1H3 |
Phytochemical cluster | No. 53 |
---|---|
KCF-S cluster | No. 7711 |
By standard InChI | CHEMBL1405 |
---|---|
By standard InChI Main Layer | CHEMBL756 CHEMBL32152 CHEMBL1405 |
By LinkDB | C00468 |
---|
By CAS RN | D004970 |
---|
class name | count |
---|---|
Liliopsida | 1 |
rosids | 1 |
family name | count |
---|---|
Arecaceae | 1 |
Lythraceae | 1 |
KNApSAcK organism | *ID | *family | *plant class | *kingdom |
---|---|---|---|---|
Phoenix dactylifera | 42345 | Arecaceae | Liliopsida | Viridiplantae |
Punica granatum | 22663 | Lythraceae | rosids | Viridiplantae |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL1405 |
CHEMBL1741321
(1)
CHEMBL1909136
(2)
|
1 / 0 |
P14061 | Estradiol 17-beta-dehydrogenase 1 | Enzyme | CHEMBL1405 |
CHEMBL864128
(1)
CHEMBL864130
(1)
CHEMBL914641 (1) CHEMBL914642 (1) CHEMBL914643 (1) CHEMBL914644 (1) CHEMBL914645 (1) CHEMBL914646 (1) CHEMBL914647 (1) CHEMBL914648 (1) CHEMBL929590 (1) CHEMBL929589 (1) CHEMBL929591 (1) CHEMBL930592 (1) CHEMBL930597 (1) CHEMBL1014266 (1) CHEMBL1013420 (1) CHEMBL1013421 (1) CHEMBL1102464 (1) CHEMBL1102466 (1) CHEMBL2208692 (1) |
0 / 0 |
P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | CHEMBL1405 |
CHEMBL1908082
(1)
|
3 / 0 |
O75795 | UDP-glucuronosyltransferase 2B17 | Enzyme | CHEMBL1405 |
CHEMBL1908091
(2)
|
1 / 0 |
Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | Electrochemical transporter | CHEMBL1405 |
CHEMBL2077601
(1)
|
1 / 0 |
O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | CHEMBL1405 |
CHEMBL2077320
(1)
|
0 / 0 |
Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | CHEMBL1405 |
CHEMBL1908087
(2)
|
0 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | CHEMBL1405 |
CHEMBL1909139
(2)
|
0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | CHEMBL1405 |
CHEMBL1909131
(2)
|
0 / 3 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | CHEMBL1405 |
CHEMBL1909190
(2)
|
2 / 2 |
P08246 | Neutrophil elastase | S1A | CHEMBL1405 |
CHEMBL1909195
(2)
|
2 / 1 |
P33765 | Adenosine receptor A3 | Adenosine receptor | CHEMBL1405 |
CHEMBL1909215
(2)
|
0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | CHEMBL1405 |
CHEMBL1909201
(2)
|
0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | CHEMBL1405 |
CHEMBL1909176
(2)
|
0 / 0 |
P29466 | Caspase-1 | C14 | CHEMBL1405 |
CHEMBL1909193
(2)
|
0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | CHEMBL1405 |
CHEMBL1909198
(2)
|
0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | CHEMBL1405 |
CHEMBL1909199
(2)
|
0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | CHEMBL1405 |
CHEMBL1909197
(2)
|
2 / 2 |
P02545 | Prelamin-A/C | Unclassified protein | CHEMBL1405 |
CHEMBL1614310
(1)
CHEMBL1614544
(1)
|
11 / 10 |
P00918 | Carbonic anhydrase 2 | Lyase | CHEMBL1405 |
CHEMBL1909123
(2)
|
1 / 2 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | CHEMBL1405 |
CHEMBL1909092
(2)
|
0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | CHEMBL1405 |
CHEMBL1909169
(2)
|
1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | CHEMBL1405 |
CHEMBL1909157
(2)
|
0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | CHEMBL1405 |
CHEMBL1909156
(2)
|
0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | CHEMBL1405 |
CHEMBL1909143
(2)
|
1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | CHEMBL1405 |
CHEMBL1909174
(2)
|
0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | CHEMBL1405 |
CHEMBL1909090
(2)
|
0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | CHEMBL1405 |
CHEMBL1909093
(2)
|
0 / 0 |
P08842 | Steryl-sulfatase | Enzyme | CHEMBL1405 |
CHEMBL1839049
(1)
|
1 / 1 |
P08183 | Multidrug resistance protein 1 | drug | CHEMBL1405 |
CHEMBL2078577
(1)
|
1 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | CHEMBL1405 |
CHEMBL1909127
(2)
|
0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | CHEMBL1405 |
CHEMBL1909204
(2)
|
0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | CHEMBL1405 |
CHEMBL1909202
(2)
|
0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL1405 |
CHEMBL1741325
(1)
CHEMBL1909135
(2)
|
0 / 1 |
P16662 | UDP-glucuronosyltransferase 2B7 | Enzyme | CHEMBL1405 |
CHEMBL1908093
(1)
|
0 / 0 |
P07237 | Protein disulfide-isomerase | Enzyme | CHEMBL756 |
CHEMBL2114826
(1)
|
0 / 0 |
P54132 | Bloom syndrome protein | Enzyme | CHEMBL1405 |
CHEMBL1614522
(1)
CHEMBL1614067
(1)
|
1 / 2 |
Q9HAW7 | UDP-glucuronosyltransferase 1-7 | Enzyme | CHEMBL1405 |
CHEMBL1908084
(1)
|
0 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | CHEMBL1405 |
CHEMBL1909203
(2)
|
1 / 11 |
P14416 | D(2) dopamine receptor | Dopamine receptor | CHEMBL1405 |
CHEMBL1909140
(2)
|
2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | CHEMBL1405 |
CHEMBL1909130
(2)
|
0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | CHEMBL1405 |
CHEMBL1909120
(2)
|
0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | CHEMBL1405 |
CHEMBL1909181
(2)
|
0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | CHEMBL1405 |
CHEMBL1909164
(2)
|
0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | CHEMBL1405 |
CHEMBL1909214
(2)
|
0 / 0 |
Q06520 | Bile salt sulfotransferase | Enzyme | CHEMBL1405 |
CHEMBL1743310
(1)
|
0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | CHEMBL1405 |
CHEMBL1909175
(2)
|
0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | CHEMBL1405 |
CHEMBL1909096
(2)
|
1 / 1 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | CHEMBL1405 |
CHEMBL1909118
(2)
|
0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | CHEMBL1405 |
CHEMBL1909166
(2)
|
1 / 0 |
P04278 | Sex hormone-binding globulin | Secreted protein | CHEMBL1405 |
CHEMBL812631
(1)
CHEMBL858260
(1)
CHEMBL809266 (1) CHEMBL809276 (1) CHEMBL922711 (1) |
0 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | CHEMBL1405 |
CHEMBL1909133
(2)
|
0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | CHEMBL1405 |
CHEMBL1614456
(2)
CHEMBL1613803
(2)
|
0 / 0 |
O75496 | Geminin | Unclassified protein | CHEMBL756 |
CHEMBL2114780
(1)
|
0 / 0 |
O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | CHEMBL1405 |
CHEMBL1908086
(1)
|
0 / 0 |
P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | CHEMBL1405 |
CHEMBL1908090
(1)
|
0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | CHEMBL1405 |
CHEMBL1909158
(2)
|
0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | CHEMBL1405 |
CHEMBL1909088
(2)
|
0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | CHEMBL1405 |
CHEMBL1909142
(2)
|
0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | CHEMBL1405 |
CHEMBL1909101
(2)
|
0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | CHEMBL1405 |
CHEMBL1909141
(2)
|
1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | CHEMBL1405 |
CHEMBL1909180
(2)
|
0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | CHEMBL1405 |
CHEMBL679678
(1)
CHEMBL673864
(1)
CHEMBL682160 (1) CHEMBL682162 (1) CHEMBL682163 (1) CHEMBL682169 (1) CHEMBL702879 (1) CHEMBL847349 (1) CHEMBL860987 (1) CHEMBL860991 (1) CHEMBL860992 (1) CHEMBL860995 (1) CHEMBL860997 (1) CHEMBL1045064 (1) CHEMBL1664695 (1) CHEMBL1909146 (2) |
0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | CHEMBL1405 |
CHEMBL1909104
(2)
|
0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | CHEMBL1405 |
CHEMBL1909144
(2)
|
0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | CHEMBL1405 |
CHEMBL1909100
(2)
|
0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | CHEMBL1405 |
CHEMBL1909167
(2)
|
1 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | CHEMBL1405 |
CHEMBL1909129
(2)
|
0 / 0 |
P08311 | Cathepsin G | S1A | CHEMBL1405 |
CHEMBL1909194
(2)
|
0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | CHEMBL1405 |
CHEMBL1909110
(2)
|
1 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | CHEMBL756 |
CHEMBL2114788
(1)
|
0 / 0 |
P03956 | Interstitial collagenase | M10A | CHEMBL1405 |
CHEMBL1909196
(2)
|
0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | CHEMBL1405 |
CHEMBL1909119
(2)
|
0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | CHEMBL1405 |
CHEMBL1794401
(1)
|
0 / 0 |
O75897 | Sulfotransferase 1C4 | Enzyme | CHEMBL1405 |
CHEMBL1743308
(1)
|
0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | CHEMBL1405 |
CHEMBL1909150
(2)
|
0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | CHEMBL1405 |
CHEMBL1909171
(2)
|
2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | CHEMBL1405 |
CHEMBL1909170
(2)
|
0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | CHEMBL1405 |
CHEMBL1909122
(2)
|
0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | CHEMBL1405 |
CHEMBL1909109
(2)
|
2 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | CHEMBL1405 |
CHEMBL1909205
(2)
|
5 / 10 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | CHEMBL1405 |
CHEMBL1909172
(2)
|
1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | CHEMBL1405 |
CHEMBL1909114
(2)
|
0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | CHEMBL1405 |
CHEMBL1909125
(2)
|
0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | CHEMBL1405 |
CHEMBL1909126
(2)
|
3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | CHEMBL1405 |
CHEMBL1909108
(2)
|
0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | CHEMBL1405 |
CHEMBL1909124
(2)
|
1 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | CHEMBL1405 |
CHEMBL1909200
(2)
|
0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | CHEMBL1405 |
CHEMBL1909207
(2)
|
2 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL1405 |
CHEMBL1741322
(1)
CHEMBL1909132
(2)
|
0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | CHEMBL1405 |
CHEMBL1614227
(2)
|
3 / 3 |
Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | CHEMBL1405 |
CHEMBL1743177
(1)
CHEMBL2077079
(1)
CHEMBL2077080 (1) CHEMBL2077540 (1) CHEMBL2076473 (1) CHEMBL2075599 (1) CHEMBL2075605 (1) CHEMBL2075606 (1) CHEMBL2076243 (1) CHEMBL2076053 (1) CHEMBL2078552 (1) |
2 / 0 |
Q01453 | Peripheral myelin protein 22 | Unclassified protein | CHEMBL1405 |
CHEMBL1614171
(1)
|
5 / 2 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | CHEMBL756 CHEMBL1405 |
CHEMBL1738588
(1)
CHEMBL1738317
(1)
|
0 / 0 |
Q9BR01 | Sulfotransferase 4A1 | Enzyme | CHEMBL1405 |
CHEMBL1743313
(1)
|
0 / 0 |
Q9HAW9 | UDP-glucuronosyltransferase 1-8 | Enzyme | CHEMBL1405 |
CHEMBL1908085
(2)
|
0 / 0 |
Q9Y4X1 | UDP-glucuronosyltransferase 2A1 | Enzyme | CHEMBL1405 |
CHEMBL1908088
(1)
|
0 / 0 |
P06133 | UDP-glucuronosyltransferase 2B4 | Enzyme | CHEMBL1405 |
CHEMBL1908092
(3)
|
0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | CHEMBL1405 |
CHEMBL1909186
(2)
|
0 / 0 |
P03372 | Estrogen receptor | NR3A1 | CHEMBL1405 |
CHEMBL679678
(1)
CHEMBL676806
(1)
CHEMBL883442 (1) CHEMBL676811 (1) CHEMBL676812 (1) CHEMBL676819 (1) CHEMBL702879 (1) CHEMBL847349 (1) CHEMBL860989 (1) CHEMBL860991 (1) CHEMBL860997 (1) CHEMBL1045063 (1) CHEMBL1102465 (1) CHEMBL1664694 (1) CHEMBL1794364 (1) CHEMBL1909145 (2) |
1 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | CHEMBL1405 |
CHEMBL1909091
(2)
|
1 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | CHEMBL1405 |
CHEMBL1909212
(2)
|
1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | CHEMBL1405 |
CHEMBL1909211
(2)
|
0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | CHEMBL1405 |
CHEMBL1909105
(2)
|
0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | CHEMBL1405 |
CHEMBL1909182
(2)
|
0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | CHEMBL1405 |
CHEMBL1909173
(2)
|
0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | CHEMBL1405 |
CHEMBL1909113
(2)
|
0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | CHEMBL1405 |
CHEMBL1909187
(2)
|
0 / 0 |
P08185 | Corticosteroid-binding globulin | Secreted protein | CHEMBL1405 |
CHEMBL665988
(1)
CHEMBL665989
(1)
CHEMBL665992 (1) CHEMBL665994 (1) CHEMBL665995 (1) CHEMBL840929 (1) CHEMBL665996 (1) CHEMBL665997 (1) |
1 / 1 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | CHEMBL1405 |
CHEMBL1909168
(2)
|
0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | CHEMBL1405 |
CHEMBL1614274
(1)
CHEMBL1613823
(1)
|
0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL1405 |
CHEMBL1741323
(1)
CHEMBL1909134
(2)
|
1 / 1 |
P37059 | Estradiol 17-beta-dehydrogenase 2 | Enzyme | CHEMBL1405 |
CHEMBL864129
(1)
|
0 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL1405 |
CHEMBL1614108
(1)
CHEMBL1613886
(1)
CHEMBL1741324 (1) CHEMBL1909138 (2) |
0 / 1 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | CHEMBL1405 |
CHEMBL1909137
(2)
|
0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | CHEMBL1405 |
CHEMBL1794483
(1)
|
0 / 0 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | CHEMBL1405 |
CHEMBL1908080
(2)
|
5 / 1 |
P10636 | Microtubule-associated protein tau | Unclassified protein | CHEMBL32152 |
CHEMBL1614421
(1)
|
4 / 3 |
P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | CHEMBL1405 |
CHEMBL1908083
(1)
|
0 / 0 |
Q53GQ0 | Estradiol 17-beta-dehydrogenase 12 | Enzyme | CHEMBL1405 |
CHEMBL914651
(1)
CHEMBL914652
(1)
|
0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | CHEMBL1405 |
CHEMBL1737980
(1)
|
0 / 0 |
P10275 | Androgen receptor | NR3C4 | CHEMBL1405 |
CHEMBL1794560
(1)
|
3 / 4 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | CHEMBL1405 |
CHEMBL1909094
(2)
|
1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | CHEMBL1405 |
CHEMBL1909087
(2)
|
0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | CHEMBL1405 |
CHEMBL1909213
(2)
|
0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | CHEMBL1405 |
CHEMBL1909089
(2)
|
0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | CHEMBL1405 |
CHEMBL1909116
(2)
|
1 / 1 |
P06239 | Tyrosine-protein kinase Lck | Src | CHEMBL1405 |
CHEMBL1909206
(2)
|
0 / 1 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | CHEMBL1405 |
CHEMBL1909128
(2)
|
0 / 0 |
P49888 | Estrogen sulfotransferase | Enzyme | CHEMBL1405 |
CHEMBL1743309
(2)
|
0 / 0 |
P56937 | 3-keto-steroid reductase | Enzyme | CHEMBL1405 |
CHEMBL914649
(1)
CHEMBL914650
(1)
CHEMBL1106724 (1) CHEMBL1106725 (1) |
0 / 0 |
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | CHEMBL1405 |
CHEMBL2354287
(1)
|
1 / 1 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
D004970 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | ABCB1 protein results in increased export of Estrone |
increases export
|
protein |
15290871
|
D004970 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | Elacridar inhibits the reaction [ABCB1 protein results in increased export of Estrone] |
decreases reaction
/ increases export |
protein |
15290871
|
D004970 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | Estrone results in decreased expression of ABCB1 protein |
decreases expression
|
protein |
16925584
|
D004970 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | Estrone results in increased expression of ABCB1 mRNA |
increases expression
|
mRNA |
15290871
|
D004970 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | Estrone results in increased expression of ABCB1 protein |
increases expression
|
protein |
15290871
|
D004970 | 9429 |
ABCG2
ABC15 ABCP BCRP BCRP1 BMDP CD338 CDw338 EST157481 GOUT1 MRX MXR MXR1 UAQTL1 |
ATP-binding cassette, sub-family G (WHITE), member 2 | Estrone results in increased expression of ABCG2 mRNA |
increases expression
|
mRNA |
16849015
|
D004970 | 8644 |
AKR1C3
DD3 DDX HA1753 HAKRB HAKRe HSD17B5 PGFS hluPGFS |
aldo-keto reductase family 1, member C3 (EC:1.3.1.20 1.1.1.188 1.1.1.239 1.1.1.64 1.1.1.112 1.1.1.357) | AKR1C3 protein results in increased metabolism of Estrone |
increases metabolic processing
|
protein |
19010312
|
D004970 | 8644 |
AKR1C3
DD3 DDX HA1753 HAKRB HAKRe HSD17B5 PGFS hluPGFS |
aldo-keto reductase family 1, member C3 (EC:1.3.1.20 1.1.1.188 1.1.1.239 1.1.1.64 1.1.1.112 1.1.1.357) | [AKR1C3 protein results in increased metabolism of Estrone] which results in increased chemical synthesis of Estradiol |
increases chemical synthesis
/ increases metabolic processing |
protein |
19010312
|
D004970 | 8644 |
AKR1C3
DD3 DDX HA1753 HAKRB HAKRe HSD17B5 PGFS hluPGFS |
aldo-keto reductase family 1, member C3 (EC:1.3.1.20 1.1.1.188 1.1.1.239 1.1.1.64 1.1.1.112 1.1.1.357) | AKR1C3 protein results in increased reduction of Estrone |
increases reduction
|
protein |
20036328
|
D004970 | 8644 |
AKR1C3
DD3 DDX HA1753 HAKRB HAKRe HSD17B5 PGFS hluPGFS |
aldo-keto reductase family 1, member C3 (EC:1.3.1.20 1.1.1.188 1.1.1.239 1.1.1.64 1.1.1.112 1.1.1.357) | [AKR1C3 protein results in increased reduction of Estrone] which results in increased chemical synthesis of Estradiol |
increases chemical synthesis
/ increases reduction |
protein |
20036328
|
D004970 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | Estrone results in increased phosphorylation of AKT1 protein |
increases phosphorylation
|
protein |
21767602
|
D004970 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | wortmannin inhibits the reaction [Estrone results in increased phosphorylation of AKT1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
21767602
|
D004970 | 250 |
ALPP
ALP PALP PLAP PLAP-1 |
alkaline phosphatase, placental (EC:3.1.3.1) | ALPP protein results in increased chemical synthesis of Estrone |
increases chemical synthesis
|
protein |
1495895
|
D004970 | 367 |
AR
AIS DHTR HUMARA HYSP1 KD NR3C4 SBMA SMAX1 TFM |
androgen receptor | Estrone binds to and results in increased activity of AR protein |
affects binding
/ increases activity |
protein |
12676605
|
D004970 | 396 |
ARHGDIA
GDIA1 NPHS8 RHOGDI RHOGDI-1 |
Rho GDP dissociation inhibitor (GDI) alpha | Estrone results in decreased expression of ARHGDIA mRNA |
decreases expression
|
mRNA |
15159206
|
D004970 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | Estrone results in increased activity of CASP3 protein |
increases activity
|
protein |
22700542
|
D004970 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | Palmitic Acid promotes the reaction [Estrone results in increased activity of CASP3 protein] |
increases activity
/ increases reaction |
protein |
22700542
|
D004970 | 840 |
CASP7
CASP-7 CMH-1 ICE-LAP3 LICE2 MCH3 |
caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) | Estrone results in increased activity of CASP7 protein |
increases activity
|
protein |
22700542
|
D004970 | 840 |
CASP7
CASP-7 CMH-1 ICE-LAP3 LICE2 MCH3 |
caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) | Palmitic Acid promotes the reaction [Estrone results in increased activity of CASP7 protein] |
increases activity
/ increases reaction |
protein |
22700542
|
D004970 | 1312 |
COMT
|
catechol-O-methyltransferase (EC:2.1.1.6) | COMT protein results in increased methylation of Estrone metabolite |
increases methylation
|
protein |
22285433
|
D004970 | 1586 |
CYP17A1
CPT7 CYP17 P450C17 S17AH |
cytochrome P450, family 17, subfamily A, polypeptide 1 (EC:1.14.99.9 4.1.2.30) | CYP17A1 protein affects the abundance of Estrone |
affects abundance
|
protein |
21427057
|
D004970 | 1588 |
CYP19A1
ARO ARO1 CPV1 CYAR CYP19 CYPXIX P-450AROM |
cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) | CYP19A1 protein affects the chemical synthesis of Estrone |
affects chemical synthesis
|
protein |
16030167
|
D004970 | 1588 |
CYP19A1
ARO ARO1 CPV1 CYAR CYP19 CYPXIX P-450AROM |
cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) | CYP19A1 protein results in increased chemical synthesis of Estrone |
increases chemical synthesis
|
protein |
16054388
|
D004970 | 1588 |
CYP19A1
ARO ARO1 CPV1 CYAR CYP19 CYPXIX P-450AROM |
cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) | Estrone analog binds to and results in decreased activity of CYP19A1 protein |
affects binding
/ decreases activity |
protein |
16039845
|
D004970 | 1588 |
CYP19A1
ARO ARO1 CPV1 CYAR CYP19 CYPXIX P-450AROM |
cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) | TNF protein promotes the reaction [CYP19A1 protein affects the chemical synthesis of Estrone] |
affects chemical synthesis
/ increases reaction |
protein |
16030167
|
D004970 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | CYP1A1 protein polymorphism results in increased hydroxylation of Estrone |
increases hydroxylation
|
protein |
15805301
|
D004970 | 1544 |
CYP1A2
CP12 P3-450 P450(PA) |
cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) | CYP1A2 protein promotes the reaction [Estrone binds to Deoxyguanosine] |
affects binding
/ increases reaction |
protein |
21907773
|
D004970 | 1545 |
CYP1B1
CP1B CYPIB1 GLC3A P4501B1 |
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) | CYP1B1 protein polymorphism affects the hydroxylation of Estrone |
affects hydroxylation
|
protein |
16207128
|
D004970 | 1545 |
CYP1B1
CP1B CYPIB1 GLC3A P4501B1 |
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) | CYP1B1 protein results in increased hydroxylation of Estrone |
increases hydroxylation
|
protein |
15763594
|
D004970 | 1545 |
CYP1B1
CP1B CYPIB1 GLC3A P4501B1 |
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) | Estrone binds to and results in decreased activity of CYP1B1 protein |
affects binding
/ decreases activity |
protein |
19563207
|
D004970 | 1576 |
CYP3A4
CP33 CP34 CYP3A CYP3A3 CYPIIIA3 CYPIIIA4 HLP NF-25 P450C3 P450PCN1 |
cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) | CYP3A4 protein promotes the reaction [Estrone binds to Deoxyguanosine] |
affects binding
/ increases reaction |
protein |
21907773
|
D004970 | 1551 |
CYP3A7
CP37 CYPIIIA7 P450-HFLA |
cytochrome P450, family 3, subfamily A, polypeptide 7 (EC:1.14.14.1) | CYP3A7 promoter polymorphism affects the abundance of Estrone |
affects abundance
|
promoter |
15985487
|
D004970 | 1551 |
CYP3A7
CP37 CYPIIIA7 P450-HFLA |
cytochrome P450, family 3, subfamily A, polypeptide 7 (EC:1.14.14.1) | CYP3A7 protein results in increased hydroxylation of Estrone |
increases hydroxylation
|
protein |
15985487
|
D004970 | 1960 |
EGR3
EGR-3 PILOT |
early growth response 3 | Estrone results in increased expression of EGR3 mRNA |
increases expression
|
mRNA |
15159206
|
D004970 | 2026 |
ENO2
NSE |
enolase 2 (gamma, neuronal) (EC:4.2.1.11) | Estrone results in decreased expression of ENO2 mRNA |
decreases expression
|
mRNA |
15159206
|
D004970 | 2099 |
ESR1
ER ESR ESRA ESTRR Era NR3A1 |
estrogen receptor 1 | Estrone binds to and results in increased activity of ESR1 protein |
affects binding
/ increases activity |
protein |
12676605
|
D004970 | 2099 |
ESR1
ER ESR ESRA ESTRR Era NR3A1 |
estrogen receptor 1 | Estrone binds to ESR1 protein |
affects binding
|
protein |
11162928
11518614 12598185 19233257 19913605 |
D004970 | 2099 |
ESR1
ER ESR ESRA ESTRR Era NR3A1 |
estrogen receptor 1 | Estrone inhibits the reaction [16 alpha-iodoestradiol binds to ESR1 protein] |
affects binding
/ decreases reaction |
protein |
9048584
|
D004970 | 2099 |
ESR1
ER ESR ESRA ESTRR Era NR3A1 |
estrogen receptor 1 | Estrone inhibits the reaction [ESR1 results in increased susceptibility to Cisplatin] |
decreases reaction
/ increases response to substance |
21767602
|
|
D004970 | 2099 |
ESR1
ER ESR ESRA ESTRR Era NR3A1 |
estrogen receptor 1 | Estrone inhibits the reaction [Estradiol binds to ESR1 protein] |
affects binding
/ decreases reaction |
protein |
12127041
|
D004970 | 2099 |
ESR1
ER ESR ESRA ESTRR Era NR3A1 |
estrogen receptor 1 | Estrone promotes the reaction [ESR1 protein alternative form binds to ESR1 protein alternative form] |
affects binding
/ increases reaction |
protein |
19233257
|
D004970 | 2099 |
ESR1
ER ESR ESRA ESTRR Era NR3A1 |
estrogen receptor 1 | Estrone promotes the reaction [ESR1 protein binds to ESR1 protein] |
affects binding
/ increases reaction |
protein |
18026938
|
D004970 | 2099 |
ESR1
ER ESR ESRA ESTRR Era NR3A1 |
estrogen receptor 1 | Estrone results in increased activity of ESR1 protein |
increases activity
|
protein |
11331656
22562034 |
D004970 | 2099 |
ESR1
ER ESR ESRA ESTRR Era NR3A1 |
estrogen receptor 1 | fulvestrant inhibits the reaction [Estrone results in increased activity of ESR1 protein] |
decreases reaction
/ increases activity |
protein |
22562034
|
D004970 | 2100 |
ESR2
ER-BETA ESR-BETA ESRB ESTRB Erb NR3A2 |
estrogen receptor 2 (ER beta) | Estrone binds to ESR2 protein |
affects binding
|
protein |
11518614
19913605 |
D004970 | 3292 |
HSD17B1
EDH17B2 EDHB17 HSD17 SDR28C1 |
hydroxysteroid (17-beta) dehydrogenase 1 (EC:1.1.1.62) | coumarin analog inhibits the reaction [[HSD17B1 protein co-treated with NADP] results in increased reduction of Estrone] |
affects cotreatment
/ decreases reaction / increases reduction |
protein |
21232530
|
D004970 | 3292 |
HSD17B1
EDH17B2 EDHB17 HSD17 SDR28C1 |
hydroxysteroid (17-beta) dehydrogenase 1 (EC:1.1.1.62) | HSD17B1 protein affects the metabolism of Estrone |
affects metabolic processing
|
protein |
16054388
|
D004970 | 3292 |
HSD17B1
EDH17B2 EDHB17 HSD17 SDR28C1 |
hydroxysteroid (17-beta) dehydrogenase 1 (EC:1.1.1.62) | [HSD17B1 protein co-treated with NADP] results in increased reduction of Estrone |
affects cotreatment
/ increases reduction |
protein |
21232530
|
D004970 | 3292 |
HSD17B1
EDH17B2 EDHB17 HSD17 SDR28C1 |
hydroxysteroid (17-beta) dehydrogenase 1 (EC:1.1.1.62) | HSD17B1 protein results in increased chemical synthesis of Estrone |
increases chemical synthesis
|
protein |
16054388
|
D004970 | 51144 |
HSD17B12
KAR SDR12C1 |
hydroxysteroid (17-beta) dehydrogenase 12 (EC:1.1.1.62) | HSD17B12 protein results in increased metabolism of Estrone |
increases metabolic processing
|
protein |
16166196
|
D004970 | 3294 |
HSD17B2
EDH17B2 HSD17 SDR9C2 |
hydroxysteroid (17-beta) dehydrogenase 2 (EC:1.1.1.62 1.1.1.239) | HSD17B2 protein affects the metabolism of Estrone |
affects metabolic processing
|
protein |
16054388
|
D004970 | 3294 |
HSD17B2
EDH17B2 HSD17 SDR9C2 |
hydroxysteroid (17-beta) dehydrogenase 2 (EC:1.1.1.62 1.1.1.239) | HSD17B2 protein results in increased chemical synthesis of Estrone |
increases chemical synthesis
|
protein |
16054388
|
D004970 | 3295 |
HSD17B4
DBP MFE-2 MPF-2 PRLTS1 SDR8C1 |
hydroxysteroid (17-beta) dehydrogenase 4 (EC:4.2.1.107 4.2.1.119 1.1.1.n12) | HSD17B4 protein affects the metabolism of Estrone |
affects metabolic processing
|
protein |
16054388
|
D004970 | 3295 |
HSD17B4
DBP MFE-2 MPF-2 PRLTS1 SDR8C1 |
hydroxysteroid (17-beta) dehydrogenase 4 (EC:4.2.1.107 4.2.1.119 1.1.1.n12) | HSD17B4 protein results in increased chemical synthesis of Estrone |
increases chemical synthesis
|
protein |
16054388
|
D004970 | 51478 |
HSD17B7
PRAP SDR37C1 |
hydroxysteroid (17-beta) dehydrogenase 7 (EC:1.1.1.62 1.1.1.270) | HSD17B7 protein affects the metabolism of Estrone |
affects metabolic processing
|
protein |
16054388
|
D004970 | 51478 |
HSD17B7
PRAP SDR37C1 |
hydroxysteroid (17-beta) dehydrogenase 7 (EC:1.1.1.62 1.1.1.270) | HSD17B7 protein results in increased chemical synthesis of Estrone |
increases chemical synthesis
|
protein |
16054388
|
D004970 | 5594 |
MAPK1
ERK ERK2 ERT1 MAPK2 P42MAPK PRKM1 PRKM2 p38 p40 p41 p41mapk |
mitogen-activated protein kinase 1 (EC:2.7.11.24) | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Estrone results in increased phosphorylation of MAPK1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
21767602
|
D004970 | 5594 |
MAPK1
ERK ERK2 ERT1 MAPK2 P42MAPK PRKM1 PRKM2 p38 p40 p41 p41mapk |
mitogen-activated protein kinase 1 (EC:2.7.11.24) | Estrone results in increased phosphorylation of MAPK1 protein |
increases phosphorylation
|
protein |
21767602
|
D004970 | 5595 |
MAPK3
ERK-1 ERK1 ERT2 HS44KDAP HUMKER1A P44ERK1 P44MAPK PRKM3 p44-ERK1 p44-MAPK |
mitogen-activated protein kinase 3 (EC:2.7.11.24) | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Estrone results in increased phosphorylation of MAPK3 protein] |
decreases reaction
/ increases phosphorylation |
protein |
21767602
|
D004970 | 5595 |
MAPK3
ERK-1 ERK1 ERT2 HS44KDAP HUMKER1A P44ERK1 P44MAPK PRKM3 p44-ERK1 p44-MAPK |
mitogen-activated protein kinase 3 (EC:2.7.11.24) | Estrone results in increased phosphorylation of MAPK3 protein |
increases phosphorylation
|
protein |
21767602
|
D004970 | 8202 |
NCOA3
ACTR AIB-1 AIB1 CAGH16 CTG26 KAT13B RAC3 SRC-3 SRC3 TNRC14 TNRC16 TRAM-1 bHLHe42 pCIP |
nuclear receptor coactivator 3 (EC:2.3.1.48) | Estrone results in increased expression of NCOA3 mRNA |
increases expression
|
mRNA |
21767602
|
D004970 | 8202 |
NCOA3
ACTR AIB-1 AIB1 CAGH16 CTG26 KAT13B RAC3 SRC-3 SRC3 TNRC14 TNRC16 TRAM-1 bHLHe42 pCIP |
nuclear receptor coactivator 3 (EC:2.3.1.48) | Estrone results in increased expression of NCOA3 protein |
increases expression
|
protein |
21767602
|
D004970 | 5154 |
PDGFA
PDGF-A PDGF1 |
platelet-derived growth factor alpha polypeptide | Estrone results in decreased expression of PDGFA mRNA |
decreases expression
|
mRNA |
10731640
|
D004970 | 5174 |
PDZK1
CAP70 CLAMP NHERF-3 NHERF3 PDZD1 |
PDZ domain containing 1 | Estrone results in increased expression of PDZK1 mRNA |
increases expression
|
mRNA |
15159206
|
D004970 | 5241 |
PGR
NR3C3 PR |
progesterone receptor | Estrone results in decreased expression of PGR mRNA alternative form |
decreases expression
|
mRNA |
15806153
|
D004970 | 5241 |
PGR
NR3C3 PR |
progesterone receptor | Estrone results in decreased expression of PGR protein alternative form |
decreases expression
|
protein |
15806153
|
D004970 | 5241 |
PGR
NR3C3 PR |
progesterone receptor | fulvestrant inhibits the reaction [Estrone results in decreased expression of PGR protein alternative form] |
decreases expression
/ decreases reaction |
protein |
15806153
|
D004970 | 6286 |
S100P
MIG9 |
S100 calcium binding protein P | Estrone results in increased expression of S100P mRNA |
increases expression
|
mRNA |
15159206
|
D004970 | 8991 |
SELENBP1
LPSB SBP56 SP56 hSBP |
selenium binding protein 1 | Estrone results in decreased expression of SELENBP1 mRNA |
decreases expression
|
mRNA |
15159206
|
D004970 | 6558 |
SLC12A2
BSC BSC2 NKCC1 |
solute carrier family 12 (sodium/potassium/chloride transporter), member 2 | Estrone results in decreased expression of SLC12A2 mRNA |
decreases expression
|
mRNA |
15159206
|
D004970 | 23657 |
SLC7A11
CCBR1 xCT |
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 | Estrone results in increased expression of SLC7A11 mRNA |
increases expression
|
mRNA |
15159206
|
D004970 | 412 |
STS
ARSC ARSC1 ASC ES SSDD XLI |
steroid sulfatase (microsomal), isozyme S (EC:3.1.6.2) | STS protein results in increased chemical synthesis of Estrone |
increases chemical synthesis
|
protein |
16054388
|
D004970 | 6818 |
SULT1A3
HAST HAST3 M-PST ST1A3/ST1A4 ST1A5 STM TL-PST |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 (EC:2.8.2.1) | Estrone affects the sulfation of SULT1A3 protein |
affects sulfation
|
protein |
11358677
|
D004970 | 6818 |
SULT1A3
HAST HAST3 M-PST ST1A3/ST1A4 ST1A5 STM TL-PST |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 (EC:2.8.2.1) | [Estrone co-treated with SULT1A3 protein] results in decreased sulfation of Ethinyl Estradiol |
affects cotreatment
/ decreases sulfation |
protein |
15483196
|
D004970 | 6783 |
SULT1E1
EST EST-1 ST1E1 STE |
sulfotransferase family 1E, estrogen-preferring, member 1 (EC:2.8.2.4) | Estrone affects the sulfation of SULT1E1 protein |
affects sulfation
|
protein |
11358677
|
D004970 | 6783 |
SULT1E1
EST EST-1 ST1E1 STE |
sulfotransferase family 1E, estrogen-preferring, member 1 (EC:2.8.2.4) | [Estrone co-treated with SULT1E1 protein] results in decreased sulfation of Ethinyl Estradiol |
affects cotreatment
/ decreases sulfation |
protein |
15483196
|
D004970 | 6783 |
SULT1E1
EST EST-1 ST1E1 STE |
sulfotransferase family 1E, estrogen-preferring, member 1 (EC:2.8.2.4) | Estrone results in decreased activity of SULT1E1 protein |
decreases activity
|
protein |
16914110
|
D004970 | 6783 |
SULT1E1
EST EST-1 ST1E1 STE |
sulfotransferase family 1E, estrogen-preferring, member 1 (EC:2.8.2.4) | SULT1E1 protein results in increased sulfation of Estrone |
increases sulfation
|
protein |
8185618
|
D004970 | 25830 |
SULT4A1
BR-STL-1 BRSTL1 DJ388M5.3 NST SULTX3 hBR-STL-1 |
sulfotransferase family 4A, member 1 (EC:2.8.2.-) | SULT4A1 protein results in increased metabolism of Estrone |
increases metabolic processing
|
protein |
12039030
|
D004970 | 7031 |
TFF1
BCEI D21S21 HP1.A HPS2 pNR-2 pS2 |
trefoil factor 1 | Estrone results in increased expression of TFF1 mRNA |
increases expression
|
mRNA |
22562034
|
D004970 | 7031 |
TFF1
BCEI D21S21 HP1.A HPS2 pNR-2 pS2 |
trefoil factor 1 | fulvestrant inhibits the reaction [Estrone results in increased expression of TFF1 mRNA] |
decreases reaction
/ increases expression |
mRNA |
22562034
|
D004970 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | TNF protein promotes the reaction [CYP19A1 protein affects the chemical synthesis of Estrone] |
affects chemical synthesis
/ increases reaction |
protein |
16030167
|
D004970 | 54658 |
UGT1A1
BILIQTL1 GNT1 HUG-BR1 UDPGT UDPGT_1-1 UGT1 UGT1A |
UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) | UGT1A1 protein results in increased glucuronidation of Estrone |
increases glucuronidation
|
protein |
15117964
15472229 |
D004970 | 54658 |
UGT1A1
BILIQTL1 GNT1 HUG-BR1 UDPGT UDPGT_1-1 UGT1 UGT1A |
UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) | UGT1A1 protein results in increased glucuronidation of Estrone analog |
increases glucuronidation
|
protein |
15472229
|
D004970 | 54575 |
UGT1A10
UDPGT UGT-1J UGT1-10 UGT1.10 UGT1J |
UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) | UGT1A10 protein results in increased glucuronidation of Estrone |
increases glucuronidation
|
protein |
15117964
15472229 |
D004970 | 54575 |
UGT1A10
UDPGT UGT-1J UGT1-10 UGT1.10 UGT1J |
UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) | UGT1A10 protein results in increased glucuronidation of Estrone analog |
increases glucuronidation
|
protein |
15472229
|
D004970 | 54659 |
UGT1A3
UDPGT UDPGT_1-3 UGT-1C UGT1-03 UGT1.3 UGT1C |
UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) | UGT1A3 protein results in increased glucuronidation of Estrone |
increases glucuronidation
|
protein |
15117964
15472229 |
D004970 | 54659 |
UGT1A3
UDPGT UDPGT_1-3 UGT-1C UGT1-03 UGT1.3 UGT1C |
UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) | UGT1A3 protein results in increased glucuronidation of Estrone analog |
increases glucuronidation
|
protein |
15472229
|
D004970 | 54577 |
UGT1A7
UDPGT UDPGT_1-7 UGT-1G UGT1-07 UGT1.7 UGT1G |
UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) | UGT1A7 protein results in increased glucuronidation of Estrone |
increases glucuronidation
|
protein |
15117964
|
D004970 | 54576 |
UGT1A8
UDPGT UDPGT_1-8 UGT-1H UGT1-08 UGT1.8 UGT1A8S UGT1H |
UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) | UGT1A8 protein results in increased glucuronidation of Estrone |
increases glucuronidation
|
protein |
15117964
15472229 |
D004970 | 54576 |
UGT1A8
UDPGT UDPGT_1-8 UGT-1H UGT1-08 UGT1.8 UGT1A8S UGT1H |
UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) | UGT1A8 protein results in increased glucuronidation of Estrone analog |
increases glucuronidation
|
protein |
15472229
|
D004970 | 54600 |
UGT1A9
HLUGP4 LUGP4 UDPGT UDPGT_1-9 UGT-1I UGT1-09 UGT1-9 UGT1.9 UGT1AI UGT1I |
UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) | UGT1A9 protein results in increased glucuronidation of Estrone |
increases glucuronidation
|
protein |
15472229
|
D004970 | 54600 |
UGT1A9
HLUGP4 LUGP4 UDPGT UDPGT_1-9 UGT-1I UGT1-09 UGT1-9 UGT1.9 UGT1AI UGT1I |
UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) | UGT1A9 protein results in increased glucuronidation of Estrone analog |
increases glucuronidation
|
protein |
15472229
|
D004970 | 7364 |
UGT2B7
UDPGT_2B9 UDPGT2B7 UDPGTH2 UGT2B9 |
UDP glucuronosyltransferase 2 family, polypeptide B7 (EC:2.4.1.17) | UGT2B7 protein results in increased glucuronidation of Estrone |
increases glucuronidation
|
protein |
15472229
|
D004970 | 7364 |
UGT2B7
UDPGT_2B9 UDPGT2B7 UDPGTH2 UGT2B9 |
UDP glucuronosyltransferase 2 family, polypeptide B7 (EC:2.4.1.17) | UGT2B7 protein results in increased glucuronidation of Estrone analog |
increases glucuronidation
|
protein |
15472229
|
D004970 | 7453 |
WARS
GAMMA-2 IFI53 IFP53 |
tryptophanyl-tRNA synthetase (EC:6.1.1.2) | Estrone results in increased expression of WARS mRNA |
increases expression
|
mRNA |
15159206
|
D004970 | 331 |
XIAP
API3 BIRC4 IAP-3 ILP1 MIHA XLP2 hIAP-3 hIAP3 |
X-linked inhibitor of apoptosis | Estrone results in increased expression of XIAP mRNA |
increases expression
|
mRNA |
21767602
|
D004970 | 331 |
XIAP
API3 BIRC4 IAP-3 ILP1 MIHA XLP2 hIAP-3 hIAP3 |
X-linked inhibitor of apoptosis | Estrone results in increased expression of XIAP protein |
increases expression
|
protein |
21767602
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#614490 | Blood group, junior system; jr |
Q9UNQ0
|
#210900 | Bloom syndrome; blm |
P54132
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
#612560 | Bone mineral density quantitative trait locus 12; bmnd12 |
O75795
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
#611489 | Corticosteroid-binding globulin deficiency |
P08185
|
#218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
#606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#143500 | Gilbert syndrome |
P22309
P22310 |
#137800 | Glioma susceptibility 1; glm1 |
P04626
|
#139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#237450 | Hyperbilirubinemia, rotor type; hblrr |
Q9Y6L6
|
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
#308100 | Ichthyosis, x-linked; xli |
P08842
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 |
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#159900 | Myoclonic dystonia |
P14416
|
#162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#601665 | Obesity |
P32245
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#172700 | Pick disease of brain |
P10636
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 |
Q9UNQ0
|
#610379 | West nile virus, susceptibility to |
P51681
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | disease name | UniProt |
---|---|---|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
Q01453 (related) |
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
|
H00027 | Ovarian cancer |
P04626
(related)
|
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P35354 (related) |
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H01163 | Corticosteroid-binding globulin (CBG) deficiency |
P08185
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00134 | X-linked ichthyosis (XLI) |
P08842
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00025 | Penile cancer |
P14780
(related)
P35354 (related) |
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
H00094 | DNA repair defects |
P54132
(related)
|
H00296 | Defects in RecQ helicases |
P54132
(related)
|
H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
MeSH disease | OMIM | compound | disease name | evidence type |
reference
pmid |
---|---|---|---|---|---|
D000230 | D004970 | Adenocarcinoma |
marker/mechanism
|
858144
5556578 |
|
D000782 | D004970 | Aneuploidy |
marker/mechanism
|
10728588
|
|
D002471 | D004970 | Cell Transformation, Neoplastic |
marker/mechanism
|
10728588
|
|
D019457 | D004970 | Chromosome Breakage |
marker/mechanism
|
10728588
|
|
D006177 | D004970 | Gynecomastia |
marker/mechanism
|
15483104
|
|
D006943 | D004970 | Hyperglycemia |
therapeutic
|
3519326
|
|
D006946 | D004970 | Hyperinsulinism |
therapeutic
|
3519326
|
|
D007006 | D004970 | Hypogonadism |
marker/mechanism
|
15483104
|
|
D007680 | D004970 | Kidney Neoplasms |
marker/mechanism
|
15610895
|
|
D010182 | D004970 | Pancreatic Diseases |
therapeutic
|
3519326
|
|
D010911 | D004970 | Pituitary Neoplasms |
marker/mechanism
|
6540183
|
|
D015175 | D004970 | Prolactinoma |
marker/mechanism
|
1657658
|
|
D011471 | D004970 | Prostatic Neoplasms |
marker/mechanism
|
858144
|
|
D014625 | D004970 | Vaginal Neoplasms |
marker/mechanism
|
5556578
|